Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Olencki

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Blood|August 1, 1988
Interleukin-3 (IL-3) stimulates the clonal growth of pulmonary alveolar macrophage of the mouse: role of IL-3 in the regulation of macrophage production outside the bone marrowB D Chen, M Mueller, T Olencki
The American Journal of Gastroenterology|December 1, 1988
Linitis plastica of the esophagusR Pazdur, T Olencki, G E Herman
Urology|March 12, 1998
Should continent diversion be performed in patients with locally advanced bladder cancer?A M Ward, T Olencki, D Peerboom, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
Pleiotropic effects of cytokines: clinical and preclinical studiesR M Bukowski, T Olencki, D McLain, et al.
Stem Cells (Dayton, Ohio)|January 1, 1993
Interleukin-2: use in solid tumorsR M Bukowski, D McLain, T Olencki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: clinical and laboratory effectsJ Tate, T Olencki, J Finke, et al.
Investigational New Drugs|September 5, 2002
A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinomaF Perez-Zincer, T Olencki, G T Budd, et al.
Investigational New Drugs|July 16, 2008
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic diseaseI Tamaskar, T Mekhail, R Dreicer, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2002
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokineticsD Z Chang, T Olencki, G T Budd, et al.
International Journal of Cancer|June 9, 1995
Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytesQ Wang, C Redovan, R Tubbs, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Blood|August 1, 1988
Interleukin-3 (IL-3) stimulates the clonal growth of pulmonary alveolar macrophage of the mouse: role of IL-3 in the regulation of macrophage production outside the bone marrowB D Chen, M Mueller, T Olencki
The American Journal of Gastroenterology|December 1, 1988
Linitis plastica of the esophagusR Pazdur, T Olencki, G E Herman
Urology|March 12, 1998
Should continent diversion be performed in patients with locally advanced bladder cancer?A M Ward, T Olencki, D Peerboom, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
Pleiotropic effects of cytokines: clinical and preclinical studiesR M Bukowski, T Olencki, D McLain, et al.
Stem Cells (Dayton, Ohio)|January 1, 1993
Interleukin-2: use in solid tumorsR M Bukowski, D McLain, T Olencki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: clinical and laboratory effectsJ Tate, T Olencki, J Finke, et al.
Investigational New Drugs|September 5, 2002
A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinomaF Perez-Zincer, T Olencki, G T Budd, et al.
Investigational New Drugs|July 16, 2008
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic diseaseI Tamaskar, T Mekhail, R Dreicer, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2002
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokineticsD Z Chang, T Olencki, G T Budd, et al.
International Journal of Cancer|June 9, 1995
Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytesQ Wang, C Redovan, R Tubbs, et al.
Pageof 3